<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078153</url>
  </required_header>
  <id_info>
    <org_study_id>111642</org_study_id>
    <secondary_id>1P30AI117970</secondary_id>
    <nct_id>NCT03078153</nct_id>
  </id_info>
  <brief_title>Effect of Social Media Support and Financial Incentives on PrEP Adherence</brief_title>
  <official_title>The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>George Washington University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if social media support and financial incentives
      improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24
      living in the Washington, DC area who are at high risk for HIV acquisition.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence To Truvada</measure>
    <time_frame>6 months</time_frame>
    <description>Level of Truvada drug levels inside red blood cells (performed by dried blood spots)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New Cases of HIV</measure>
    <time_frame>6 months</time_frame>
    <description>Number of reactive HIV rapid and 4th generation tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of STIs</measure>
    <time_frame>6 months</time_frame>
    <description>Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pre-Exposure Prophylaxis</condition>
  <arm_group>
    <arm_group_label>Financial Incentive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provided financial incentive at 3-month and 6-month follow-up visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Media Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provided social media support through a facebook group for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Financial Incentive</intervention_name>
    <description>Participants will receive a $50 gift card at 3- and 6- month follow-up visits.</description>
    <arm_group_label>Financial Incentive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Media Group</intervention_name>
    <description>Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP</description>
    <arm_group_label>Social Media Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male assigned at birth (regardless of current gender identity)

          -  Age 18-24

          -  Black/African American, Latino or Asian

          -  HIV negative

          -  History of unprotected anal sex with a man in the last 6 months

          -  Living within the DC metropolitan statistical area and anticipate remaining within the
             DC area for the next 6 months

          -  Not enrolled in any other HIV prevention trial

          -  Interested in taking PrEP

          -  Not a current PrEP user and have not taken PrEP in the last 30 days

          -  Able to provide informed consent

        Exclusion Criteria:

          -  Female sex at birth

          -  Age younger than 18 or older than 24

          -  Caucasian

          -  HIV positive

          -  Actively taking PrEP or having taken PrEP within 30 days of enrollment

          -  Chronic hepatitis B infection

          -  Known renal insufficiency

          -  On probation or parole

          -  Any other conditions that the Principal Investigator may consider a contraindication
             to enrolling in the study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>male at birth (regardless of current gender identity)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Siegel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The GW Medical Faculty Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hilary Wolf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Georgetown University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chelsea Ware, MS</last_name>
    <phone>202-677-6496</phone>
    <email>cware@mfa.gwu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>MedStar Health</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chelsea Ware, MS</last_name>
      <phone>202-677-6496</phone>
      <email>cware@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Ruth Kanthula, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The GW Medical Faculty Associates</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Ware, MS</last_name>
      <phone>202-677-6496</phone>
      <email>cware@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Siegel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Marc O. Siegel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

